Concepedia

FRI0470 A phase 2 study of safety and efficacy of lenabasum (JBT-101), a cannabinoid receptor type 2 agonist, in refractory skin-predominant dermatomyositis

Victoria P. Werth, Emily Z. Hejazi, S.M. Peña, J Háber, Joyce Okawa, Ru Feng, K. Gabre, Josef Concha, C. Cornwall, Nancy Dgetluck,

Annals of the Rheumatic Diseases · 2018 · 21 citations · 3 references

DOIFull text

Open access

Concepts

References

3

Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study

Jérôme Avouac, Ulrich A. Walker, É. Hachulla et al. · Annals of the Rheumatic Diseases · 2014 · 145 citations · Full text

, , +14

Exercise peripheral oxygen saturation (Spo2) accurately reflects arterial oxygen saturation (Sao2) and predicts mortality in systemic sclerosis

Jeffrey J. Swigris, Xuezhi Zhou, F. S. Wamboldt et al. · Thorax · 2009 · 63 citations · Full text

, , +13

Interstitial lung disease in systemic sclerosis - A simple staging system

UCL Discovery (University College London) · 2008 · 61 citations

, , +17